INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people fromHPV-relateddiseases, cancer, and infectious diseases, today announced the pricing of an underwritten public offering of 14,285,715 shares of its common stock and accompanying Series A warrants to purchase up to 14,285,715 shares of its […]
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) WilsonEncourages Investors Who Suffered Losses In PepGen To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in PepGenbetween March 7, 2024 and March 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly
(TSX-V:DGHI),(NASDAQ:DGHI),(NASDAQ:DGXX),(TSX-V:DGX),(NASDAQ:NNE), This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MIAMI, July 03, 2025 (GLOBE NEWSWIRE) — Digi
(TSX-V:MD), MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to report the beginning of his prospecting campaign in the Digeridoo area on its Willbob-Kan gold project, wholly owned by Midland. The Willbob-Kan project covers several tens of kilometers of stratigraphy and structures that are highly favorable for gold.
(TSX:BBD-A),(TSX:BBD-B),(OTC US:BDRBF),(Other OTC:BDRBF), MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the second quarter of 2025 on July 31st, 2025. Financial results for the second quarter of 2025 Eric Martel, President and Chief Executive Officer, Bombardier, and Bart Demosky, Executive Vice President and Chief Financial Officer, Bombardier,
(NASDAQ:KURA), SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on July 1, 2025, the Compensation Committee of the Company's Board of Directors (the “Compensation Committee”) granted inducement awards
Digi Power X Announces Proposed Shares for Debt Settlement with NANO Nuclear Energy GlobeNewswire July 03, 2025 This news release constitutes a “designated news release” for the purposes of the Company's prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025. NOT FOR DISTRIBUTION TO U.S. NEWS WIRE
Midland Begins Exploration Work on the Willbob-Kan Gold Project in the Labrador Trough GlobeNewswire July 03, 2025 MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to report the beginning of his prospecting campaign in the Digeridoo area on its Willbob-Kan gold project, wholly owned by Midland. The Willbob-Kan
Bombardier to Report Second Quarter 2025 Financial Results on July 31st, 2025 GlobeNewswire July 03, 2025 MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) will publish its financial results for the second quarter of 2025 on July 31st, 2025. Financial results for the second quarter of 2025 Eric Martel, President and Chief Executive
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 03, 2025 SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on July 1, 2025, the Compensation